AzTrials
AzTrials

Side EffectNCT04205253

Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue

An observational study of Side Effect and Ischemia Reperfusion Injury, run by Selcuk University at 2 sites in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to detect tongue edema associated with the pressure exerted by a rigid direct laryngoscope by measuring the tongue area using USG in patients undergoing suspension laryngoscopy (SL) procedures. Read more about this study

Who is it for?
Ages 20 to 65 years
Conditions the study is for
Side Effect, Ischemia Reperfusion Injury, Edema
What is being tested?
Ultrasonography imaging
How many people
64 participants
Where
2 sitesTurkey (Türkiye)
Study dates
1 Oct 2018to 1 Apr 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients aged 20 years or older who will undergo suspension laryngoscopy procedures or who did not need suspension larygoscopy procedures.

Who may be able to join

  • Patients aged 20 years or older
  • Patients who undergo suspension laryngoscope procedure
  • Patients aged 20 years or older Patients who did not need suspension laryngoscopy and any head and neck procedures

Who cannot join

  • refusal to participate
  • age of <20 years
  • history of syndromal craniofacial abnormalities
  • occurrence of tongue masses
  • history of craniofacial surgery
  • history of burns, trauma or radiotherapy involving the head and neck region
Show all 10Show fewer
  • neurologic disorders and patients with obstructive sleep apnea syndrome (OSAS)
  • active inflammation in the head and neck region
  • cervical rigidity limiting neck flexion and head extension
  • Control group

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Selcen Celik

    Konya, Selcuklu, 42100

  • Selcuk University

    Konya, Selcuklu, 42100

Other trials in Turkey (Türkiye)

About this study

Official title: Is it Possible That Direct Rigid Laryngoscope-related Ischemia-Reperfusion Injury Occurs in the Tongue During Suspension Laryngoscopy as Detected by Ultrasonography: A Prospective Controlled Study

This study aimed to detect tongue edema associated with the pressure exerted by a rigid direct laryngoscope by measuring the tongue area using USG in patients undergoing suspension laryngoscopy (SL) procedures.

Read the detailed description

Suspension laryngoscopy (SL) is a surgical procedure for both diagnostic and therapeutic purposes. In this procedure, a rigid direct laryngoscope is inserted orally, and the tongue and the base of the tongue are compressed.The tongue is an ideal organ for evaluation with ultrasonography. This study aimed to detect the occurrence of tongue edema through ultrasonography examination due to the rigid direct laryngoscope in SL procedures.

Being tested
Ultrasonography imaging
Keywords
tongue, ischemia-reperfusion injury, side effect, edema, suspension laryngoscopy
Medical subject headings
Reperfusion Injury, Edema, Macroglossia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasonography imagingDiagnostic test

    This study aimed to evaluate the tongue areas and compare the tongue areas before the implementation of rigid direct laryngoscope and after the rigid direct laryngoscope.

Study groups in NCT04205253
Study groupRoleWhat they receive
StudyThe first group is the study group. Patients aged 20 years or older and were to undergo suspension laryngoscopy procedure were eligible for inclusion in this group. Tongue areas were measured twice by submental USG. The first measurements (TA1) were done immediately after endotracheal intubation before introducing the rigid direct laryngoscope, whereas the second measurements (TA2) were done after the SL procedure and after removing the rigid direct laryngoscope just before extubation.The difference between TA2 and TA1 (i.e., TA2-TA1) were used to define the occurrence of tongue edema as study group.
Receives: Diagnostic Test: Ultrasonography imaging
ControlThe second group was the control group, which included patients who did not need SL and any head and neck procedures.The tongue areas of these patients were measured twice by submental USG as in the study group. The TA1 measurements were done immediately after endotracheal intubation, whereas the TA2 measurements were done at the end of the surgical procedure just before extubation. The difference between TA2 and TA1 (i.e., TA2-TA1) were used to define the occurrence of tongue edema as study group.
Receives: Diagnostic Test: Ultrasonography imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of change in tongue area.

    This study aimed to measure the change in tongue areas before and after the implementation of rigid direct laryngoscope by using ultrasonography imaging.

    Measured: 2018-2019 (6 months)

Secondary outcomes (1)
  1. Rate of formation in tongue edema.

    This study aimed to measure the formation of tongue edema due to the rigid direct laryngoscope by using ultrasonography imaging.

    Measured: 2018 (6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2019
  2. Study start1 Oct 2018
  3. Primary completion1 Apr 2019
  4. Study completion1 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04205253
Sponsor's protocol ID
2018/330
Status last verified
Dec 2019
First submitted
17 Dec 2019
Last updated
19 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data has been planned to share after publishing as a article in a journal.

Publications

  • Onal M, Colpan B, Elsurer C, Bozkurt MK, Onal O, Turan A. Is it possible that direct rigid laryngoscope-related ischemia-reperfusion injury occurs in the tongue during suspension laryngoscopy as detected by ultrasonography: a prospective controlled study. Acta Otolaryngol. 2020 Jul;140(7):583-588. doi: 10.1080/00016489.2020.1743353. Epub 2020 Mar 30.

    PubMed 32223688

Questions about this trial

What is this clinical trial studying?

An observational study of Side Effect and Ischemia Reperfusion Injury, run by Selcuk University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of change in tongue area. (time frame: 2018-2019 (6 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04205253, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2019; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in